Merck to acquire Prometheus Biosciences for $10.8bn 17-Apr-2023 By Rachel Arthur Merck will acquire Prometheus Biosciences, a San Diego biotech working on a precision medicine approach for developing therapeutics for the treatment of immune-mediated diseases.
Merck KGaA invests in France, boosts production capacity for mAbs 04-Oct-2022 By Jane Byrne Merck KGaA has opened a facility to support the delivery of its new Millipore CTDMO services at its site in Martillac, France.
